Lee Sang Mi, Kim Hyun Uk
Systems Biology and Medicine Laboratory, Department of Chemical and Biomolecular Engineering (BK21 four), Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
KAIST Institute for Artificial Intelligence, KAIST, Daejeon 34141, Republic of Korea.
Mol Omics. 2021 Dec 6;17(6):881-893. doi: 10.1039/d1mo00337b.
Identification of novel biomarkers has been an active area of study for the effective diagnosis, prognosis and treatment of cancers. Among various types of cancer biomarkers, metabolic biomarkers, including enzymes, metabolites and metabolic genes, deserve attention as they can serve as a reliable source for diagnosis, prognosis and treatment of cancers. In particular, efforts to identify novel biomarkers have been greatly facilitated by a rapid increase in the volume of multiple omics data generated for a range of cancer cells. These omics data in turn serve as ingredients for developing computational models that can help derive deeper insights into the biology of cancer cells, and identify metabolic biomarkers. In this review, we provide an overview of omics data generated for cancer cells, and discuss recent studies on computational models that were developed using omics data in order to identify effective cancer metabolic biomarkers.
鉴定新型生物标志物一直是癌症有效诊断、预后和治疗研究的活跃领域。在各类癌症生物标志物中,代谢生物标志物,包括酶、代谢物和代谢基因,值得关注,因为它们可作为癌症诊断、预后和治疗的可靠依据。特别是,为一系列癌细胞生成的多组学数据量的快速增加极大地促进了新型生物标志物的鉴定工作。这些组学数据反过来又成为开发计算模型的要素,这些模型有助于深入了解癌细胞生物学,并识别代谢生物标志物。在本综述中,我们概述了为癌细胞生成的组学数据,并讨论了最近利用组学数据开发的用于识别有效癌症代谢生物标志物的计算模型的研究。